0000899243-23-001064.txt : 20230105
0000899243-23-001064.hdr.sgml : 20230105
20230105194914
ACCESSION NUMBER: 0000899243-23-001064
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230103
FILED AS OF DATE: 20230105
DATE AS OF CHANGE: 20230105
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Brennan Nora
CENTRAL INDEX KEY: 0001790215
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35006
FILM NUMBER: 23513214
MAIL ADDRESS:
STREET 1: C/O TELA BIO, INC.
STREET 2: 1 GREAT VALLEY PARKWAY, SUITE 24
CITY: MALVERN
STATE: PA
ZIP: 19355
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: SPECTRUM PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0000831547
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 930979187
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 11500 S. EASTERN AVE., SUITE 240
CITY: HENDERSON
STATE: NV
ZIP: 89052
BUSINESS PHONE: 702-835-6300
MAIL ADDRESS:
STREET 1: 11500 S. EASTERN AVE., SUITE 240
CITY: HENDERSON
STATE: NV
ZIP: 89052
FORMER COMPANY:
FORMER CONFORMED NAME: NEOTHERAPEUTICS INC
DATE OF NAME CHANGE: 19960819
FORMER COMPANY:
FORMER CONFORMED NAME: AMERICUS FUNDING CORP
DATE OF NAME CHANGE: 19920703
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2023-01-03
0
0000831547
SPECTRUM PHARMACEUTICALS INC
SPPI
0001790215
Brennan Nora
2 ATLANTIC AVENUE, 6TH FLOOR
BOSTON
MA
02110
0
1
0
0
See Remarks
Common Stock, $0.001 par value
2023-01-03
4
A
0
240000
0.00
A
600215
D
Stock Option (Right to Buy)
0.38
2023-01-03
4
A
0
840000
0.00
A
2033-01-03
Common Stock
840000
840000
D
One third of the aggregate amount of restricted stock units shall vest on each of January 3, 2024, 2025 and 2026, respectively.
One third of the aggregate amount of option shares shall vest on each of January 3, 2024, 2025 and 2026, respectively.
Executive Vice President and Chief Financial Officer
/s/ Keith M. McGahan, Attorney-in-Fact for Nora E. Brennan
2023-01-05